24TH CONGRESS OF THE POLISH NEUROLOGICAL SOCIETY (PTN CONGRESS 2021)

 

, 15.09.2021 - 18.09.2021

PROGRAM

Print version of the program
15
September
Wednesday
17:00 - 20:00
OPENING SESSION
Speakers:
Jarosław Sławek
prof. dr hab. n. med. Jarosław Sławek
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
Opening address
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
Information on the term of office of PTN Board
Jarosław Sławek
prof. dr hab. n. med. Jarosław Sławek
Presentation of election results: new President-Elect and General Board of the Polish Neurological Society
In memoriam of neurologists who passed away in 2017-2020
Alina Kułakowska
prof. dr hab. n. med. Alina Kułakowska
Ceremonial presentation of diplomas and honorary titles:
Honorary member of PTN:
prof. Hans Peter Hartung
Laudation: prof. dr hab. n. med. Konrad Rejdak

prof. Bernhard Landwehrmeyer
Laudation prof. dr hab. n. med. Jarosław Sławek

prof. dr hab. n. med. Danuta Ryglewicz
Laudation: prof. dr hab. n. med. Halina Sienkiewicz-Jarosz

prof. dr hab. n. med. Krystyna Barbara Pierzchała
Laudation: prof. dr hab. n. med. Monika Adamczyk-Sowa


Honorary president of PTN title:
prof. dr hab. n. med. Anna Członkowska
Laudation: prof. dr hab. n. med. Alina Kułakowska


Presentation of the Jubilee Diploma:
prof. dr hab. n. med. Teofan Domżał
Laudacja: prof. dr hab. n. med. Andrzej Potemkowski

PTN Awards:

W. Jakimowicz Award
dr n. med. Wojciech Guenter

J. Babinski Award
dr n. med. Adam Wiśniewski
dr n. med. Łukasz Smoliński
dr n.med. Marta Waliszewska-Prosół
dr hab. n. med. Alicja Kalinowska-Łyszczarz
dr n. med. Jarosław Dulski

Presidential Award
dr. n. med. Natalia Szejko

Thanks to representatives of patient organizations
Tomasz Połeć, Polskie Towarzystwo Stwardnienia Rozsianego
Dominika Czarnotra, Polskie Towarzystwo Stwardnienia Rozsianego
Malina Wieczorek, Fundacja SM "Walcz o siebie"
Wojciech Machajek , Fundacja Chorób Mózgu
Inaugural addresses:
Welcome from the EAN President
prof. Claudio Bassetti
The mission of EAN for European neurologists and neurology
Dafin Muresanu
Dafin Muresanu
Preclinical phase of MS
Gavin Giovannoni
MBBCH, PhD Gavin Giovannoni
Research on biomarkers in spinocerebellar ataxia type 3 (SCA3) and type 7 (SCA7)
Zbigniew Wszołek
Zbigniew Wszołek
13:00 - 16:00
GENERAL ASSEMBLY OF PTN DELEGATES
16
September
Thursday
14:00 - 15:00
SPONSORED SESSION
14:00 - 14:30
Lecture sponsored by
Therapeutic algorithm for Parkinson's disease with focus on dopaminergic agonists
Jarosław Sławek
prof. dr hab. n. med. Jarosław Sławek
14:30 - 14:35
DISCUSSION
14:35 - 14:55
Lecture sponsored by

Buccolam® - new therapeutic option for the treatment of epileptic state available in Poland
Maria Mazurkiewicz-Bełdzińska
Maria Mazurkiewicz-Bełdzińska
14:55 - 15:00
DISCUSSION
15:00 - 16:30
REVIEW SESSION: EPILEPSY
Chairs:
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
Danuta Ryglewicz
Danuta Ryglewicz
15:00 - 15:20
Modern diagnostics of selected epilepsy syndromes
Maria Mazurkiewicz-Bełdzińska
Maria Mazurkiewicz-Bełdzińska
15:20 - 15:40
Autoimmune epilepsy syndromes
Halina Sienkiewicz-Jarosz
Halina Sienkiewicz-Jarosz
15:40 - 16:00
Current treatment options in epilepsy – AD 2021
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
16:00 - 16:20
Surgical methods to treat epilepsy
Dariusz Jaskółski
Dariusz Jaskółski
16:20 - 16:30
DISCUSSION
16:30 - 16:45
BREAK
14:00 - 15:00
SESSION SPONSORED BY
ZEPOSIA – NOWA GENERACJA SELEKTYWNEGO MODULATORA RECEPTORA S1P W LECZENIU RRMS
Chair:
Pharmacokinetics and mechanism of action of ozanimod
Marcin Mycko
Marcin Mycko
Ozanimod efficacy and examples of use
Safety profile and patient monitoring in the course of ozanimod therapy
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
DISCUSSION
15:00 - 16:30
REVIEW SESSION: SLEEP DISORDERS
Chair:
Andrzej Bogucki
Andrzej Bogucki
15:00 - 15:20
COVID-19 and sleep disorders
Andrzej Bogucki
Andrzej Bogucki
15:20 - 15:40
Narcolepsy and other hypersomnias
Aleksandra Wierzbicka-Wichniak
Aleksandra Wierzbicka-Wichniak
15:40 - 16:00
Sleep disorders in neurodegenerative diseases
Monika Rudzińska-Bar
Monika Rudzińska-Bar
16:00 - 16:20
Pharmacotherapy for insomnia
Monika Białecka
Monika Białecka
16:20 - 16:30
DISCUSSION
16:30 - 16:45
BREAK
15:00 - 16:30
REVIEW SESSION: NEURO-ONCOLOGY
Chair:
Sławomir Michalak
Sławomir Michalak
15:00 - 15:25
Neuroimaging of radiation therapy sequelae in the CNS
Jerzy Walecki
Jerzy Walecki
15:25 - 15:50
Neuropathology of radiation therapy and chemotherapy sequelae in CNS tumors
Przemysław Nowacki
Przemysław Nowacki
15:50 - 16:10
Clinical presentation of radiation therapy sequelae and their management
Sławomir Michalak
Sławomir Michalak
16:10 - 16:25
Clinical presentation of radiation therapy sequelae and their management
Joanna Rybacka-Mossakowska
16:25 - 16:30
DISCUSSION
16:30 - 16:45
BREAK
Hall A
16:45 - 18:15
PRESIDENTS' SESSION - PLENARY
Chairs:
Jarosław Sławek
prof. dr hab. n. med. Jarosław Sławek
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
16:45 - 17:05
Key advances in the treatment of brain disorders (2017-2020)
Jarosław Sławek
prof. dr hab. n. med. Jarosław Sławek
17:05 - 17:25
State-of-the-art technologies in neurology
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
17:25 - 17:45
Progress in multiple sclerosis
17:45 - 18:05
Gene therapy in Huntington's Disease and other movement disorders
18:05 - 18:15
DISCUSSION
18:15 - 18:30
BREAK
18:30 - 19:30
SPONSORED SESSION OF PLATINUM SPONSOR
Chair:
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
18:30 - 18:35
Milestones in the management of neurological disorders - from scientific discoveries to clinical practice
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
18:35 - 18:50
Early and effective therapy as a key to inhibiting MS progression
Monika Adamczyk-Sowa
Monika Adamczyk-Sowa
18:50 - 19:05
Natalizumab – optimizing management of patients with high disease activity. Summary of RWE
Alina Kułakowska
prof. dr hab. n. med. Alina Kułakowska
19:05 - 19:20
Nusinersen – observations and conclusions from clinical practice
19:20 - 19:30
DISCUSSION
19:30 - 19:45
BREAK
19:45 - 21:15
REVIEW SESSION: VASCULAR DISORDERS
Chairs:
Anna Członkowska
Anna Członkowska
Adam Kobayashi
Adam Kobayashi
19:45 - 20:05
Cerebral amyloid angiopathy
Przemysław Nowacki
Przemysław Nowacki
20:05 - 20:25
Sporadic cerebral small vessel disease
Jacek Staszewski
20:25 - 20:45
Fibromuscular dysplasia
Adam Kobayashi
Adam Kobayashi
20:45 - 21:05
Stroke prevention- still essential
Anna Członkowska
Anna Członkowska
21:05 - 21:15
DISCUSSION
19:45 - 21:15
REVIEW SESSION: EXTRAPYRAMIDAL DISORDERS
Chairs:
Andrzej Friedman
Andrzej Friedman
Andrzej Bogucki
Andrzej Bogucki
19:45 - 20:05
Understanding the pathogenesis of Parkinson's disease - impact of genetic factors
Dariusz Koziorowski
Dariusz Koziorowski
20:05 - 20:25
Role of biomarkers in the diagnosis of Parkinson’s disease
Sławomir Budrewicz
Sławomir Budrewicz
20:25 - 20:45
Parkinson’s disease during the COVID pandemic
Monika Rudzińska-Bar
Monika Rudzińska-Bar
20:45 - 21:05
Gait and postural disorders in Parkinson’s disease
Jarosław Sławek
prof. dr hab. n. med. Jarosław Sławek
21:05 - 21:15
DISCUSSION
19:45 - 21:25
REVIEW SESSION: NEUROMUSCULAR DISORDERS
What's new in the diagnosis and treatment of neuromuscular disorders
Chairs:
Magdalena Koszewicz
Magdalena Koszewicz
19:45 - 20:05
Myasthenia gravis
20:05 - 20:25
Guillain–Barré syndrome
Urszula Chyrchel-Paszkiewicz
Urszula Chyrchel-Paszkiewicz
20:25 - 20:45
Chronic inflammatory demyelinating polyneuropathy
Anna Potulska-Chromik
Anna Potulska-Chromik
20:45 - 21:05
Small-fibre neuropathies
Magdalena Koszewicz
Magdalena Koszewicz
21:05 - 21:25
Amyotrophic lateral sclerosis
Magdalena Kuźma-Kozakiewicz
Magdalena Kuźma-Kozakiewicz
17
September
Friday
15:00 - 16:30
REVIEW SESSION: MULTIPLE SCLEROSIS
Chairs:
Halina Bartosik-Psujek
Halina Bartosik-Psujek
Monika Adamczyk-Sowa
Monika Adamczyk-Sowa
15:00 - 15:20
New insights into the clinical course of multiple sclerosis
Halina Bartosik-Psujek
Halina Bartosik-Psujek
15:20 - 15:40
Therapeutic lag – a new problem in the treatment of MS
Alicja Kalinowska
Alicja Kalinowska
15:40 - 16:00
Advent of a new era in MS treatment
Monika Adamczyk-Sowa
Monika Adamczyk-Sowa
16:00 - 16:20
The role of autologous haematopoietic stem cell transplant in MS therapy
Alina Kułakowska
prof. dr hab. n. med. Alina Kułakowska
16:20 - 16:30
DISCUSSION
16:30 - 16:45
BREAK
15:00 - 16:30
REVIEW SESSION: PAIN SYNDROMES IN NEUROLOGY
Chairs:
Jacek Rożniecki
Jacek Rożniecki
Wojciech Kozubski
Wojciech Kozubski
15:00 - 15:20
Benefits of correct diagnosis of idiopathic headache in light of new therapies of the 21st century
Izabela Domitrz
Izabela Domitrz
15:20 - 15:40
Prophylactic treatment of migraine in light of guidelines of the Polish Headache Society (PTBG)
Wojciech Kozubski
Wojciech Kozubski
15:40 - 16:00
New horizons in migraine therapy
Adam Stępień
Adam Stępień
16:00 - 16:20
Indomethacin-responsive headaches
Jacek Rożniecki
Jacek Rożniecki
16:20 - 16:30
DISCUSSION
16:30 - 16:45
BREAK
15:00 - 16:30
REVIEW SESSION: NEUROREHABILITATION
Chairs:
Beata Łabuz-Roszak
Beata Łabuz-Roszak
Józef Opara
Józef Opara
15:00 - 15:25
Classification and assessment of gait disorders for neurorehabilitation
Iwona Sarzyńska-Długosz
Iwona Sarzyńska-Długosz
15:25 - 15:50
Basics of gait analysis
Marcin Bonikowski
Marcin Bonikowski
15:50 - 16:15
Different strategies for gait re-education in various disorders of the nervous system
Maciej Krawczyk
Maciej Krawczyk
16:15 - 16:30
DISCUSSION
16:30 - 16:45
BREAK
Hall A
16:45 - 17:45
PLATINUM SPONSOR SESSION
Chair:
16:45 - 17:15
How can we inhibit MS in clinical practice – recent clinical trial results for ocrelizumab
17:15 - 17:45
How do we improve therapeutic outcomes in all SMA patients. Evrysdi – a breakthrough in the treatment of spinal muscular atrophy
Risdiplam in SMA1
How are we altering our management of SMA 2/3
17:45 - 18:00
BREAK
18:00 - 19:30
PLENARY SESSION: WAYS TO REFORM POLISH NEUROLOGY
Chairs:
Jarosław Sławek
prof. dr hab. n. med. Jarosław Sławek
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
18:00 - 18:25
Neurological disorders as a civilizational challenge
Jarosław Sławek
prof. dr hab. n. med. Jarosław Sławek
18:25 - 18:50
Presentation of the White Paper on Neurology
Małgorzata Gałązka-Sobotka
Małgorzata Gałązka-Sobotka
18:50 - 19:15
Challanges in polish neurology - introduction to the debate
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
19:15 - 19:40
Debate: Opportunities for systemic solutions in neurology
dr hab. Małgorzata Gałązka-Sobotka, Institute of Management in Healthcare, Łazarski University

prof. dr hab. n. med Anna Latos-Bieleńska, Chair and Department of Medical Genetics i Poznań

dr Grażyna Lesyng-Pawłowska, National Chamber of Physicians

Minister Maciej Miłkowski, Ministry of Health

prof. Konrad Rejdak, President-Elect of the Polish Neurological Society

prof. Jarosław Sławek, President of the Polish Neurological Society

prof. dr hab. n. med. Agnieszka Słowik, National Consultant for Neurology
19:40 - 19:45
DISCUSSION
19:45 - 20:45
SESSION SPONSORED BY
Let’s talk about MS

Chair:
Alicja Kalinowska
Alicja Kalinowska
Management of female patients versus pregnancy
Monika Adamczyk-Sowa
Monika Adamczyk-Sowa
Brain atrophy as a marker of therapeutic efficacy
Alicja Kalinowska
Alicja Kalinowska
Escalation versus reconstitution therapy – physician’s choice
Marcin Mycko
Marcin Mycko
20:45 - 21:05
LECTURE SPONSOREDY BY
Degeneration and acute spinal pain - effective pharmacotherapy
Wojciech Kozubski
Wojciech Kozubski
19:45 - 21:00
SPONSORED SESSION OF PLATINUM PARTNER:
Chair:
Mariusz Stasiołek
Mariusz Stasiołek
19:45 - 19:50
Introduction
Mariusz Stasiołek
Mariusz Stasiołek
19:50 - 20:10
Mild cognitive impairment vs Alzheimer's disease
Agnieszka Gorzkowska
Agnieszka Gorzkowska
20:10 - 20:25
Sources of medical information
Anna Jurewicz
20:25 - 20:45
How to shorten the time to MS diagnosis and treatment, based on Czech experience
Dana Horáková, MD, PhD
Ph.D. Dana Horáková, MD, PhD
20:45 - 21:00
DISCUSSION
19:45 - 20:10
PATRONAGE TO THE LECTURE:
Excessive drowsiness - challenges in neurological practice. Modafinil, new therapeutic option
Adam Wichniak
Adam Wichniak
20:10 - 20:15
Discussion
20:15 - 21:15
SESSION SPONSORED BY

HOW TO ACCELERATE ACCESS TO STATE-OF-THE-ART THERAPIES IN PARKINSON'S DISEASE AND SPASTICITY?
Chair:
Jarosław Sławek
prof. dr hab. n. med. Jarosław Sławek
20:15 - 20:30
Can a patient with advanced Parkinson's disease return to fitness?
Dariusz Koziorowski
Dariusz Koziorowski
20:30 - 20:40
Which patients with advanced Parkinson’s disease can be helped when oral therapies fail?
Agnieszka Gorzkowska
Agnieszka Gorzkowska
20:40 - 20:50
Patients’ path to advanced therapies in Parkinson's disease
Joanna Siuda
Joanna Siuda
20:50 - 21:00
Early diagnosis of post-stroke spasticity as a chance for better quality of life
Iwona Sarzyńska-Długosz
Iwona Sarzyńska-Długosz
21:00 - 21:15
DISCUSSION
18
September
Saturday
8:00 - 9:30
REVIEW SESSION: DEMENTIA DISEASES
Chair:
Maria Barcikowska
Maria Barcikowska
8:00 - 8:25
Diet and exercise in the fight against dementia
Anna Barczak
Anna Barczak
8:25 - 8:50
Have the Taoists finally won?
Maria Barcikowska
Maria Barcikowska
8:50 - 9:15
Treatment of neuropsychiatric disorders in dementia - present and future options
Tomasz Gabryelewicz
Tomasz Gabryelewicz
9:15 - 9:30
DISCUSSION
9:30 - 9:45
BREAK
9:45 - 11:15
REVIEW SESSION OF YOUNG NEUROLOGISTS
Chair:
Stanisław Szlufik
Stanisław Szlufik
9:45 - 10:05
History of the Polish and European Sections of Young Neurologists
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
10:05 - 10:25
Specialty training in neurology in Poland and across Europe: advantages and disadvantages of the Polish specialty training programme
10:25 - 10:45
Opportunities for a scientific career for young neurologists in Poland and in Europe: a comparison
Stanisław Szlufik
Stanisław Szlufik
10:45 - 11:05
Neurology: is it better to be a clinician or a scientist?
Aleksandra Pietruczuk
Aleksandra Pietruczuk
11:05 - 11:15
DISCUSSION
11:15 - 11:30
BREAK
11:30 - 13:15
SPONSORED SESSION
11:30 - 11:50
PRESENTATION SPONSORED BY Novartis
Gene therapy for SMA
Katarzyna Kotulska-Jóźwiak
Katarzyna Kotulska-Jóźwiak
11:50 - 13:00
SESSION SPONSORED BY Boehringer
PREVENTION AND TREATMENT OF CEREBRAL STROKE
Chair:
Agnieszka Słowik
Agnieszka Słowik
11:50 - 12:10
Reversing anticoagulation activity of NOAC in patients with acute phase of ischemic stroke vs thrombolytic therapies
Bożena Adamkiewicz
Bożena Adamkiewicz
12:10 - 12:30
Thrombolysis preceding mechanical thrombectomy - what do we see in recent data
Michał Karliński
Michał Karliński
12:30 - 12:50
Anticoagulants in patients with atrial fibrillation and a history of cerebral stroke
Agnieszka Słowik
Agnieszka Słowik
12:50 - 13:00
DISCUSSION
13:00 - 13:15
BREAK
8:00 - 9:30
VIDEO SESSION: MOVEMENT DISORDERS
Chair:
Jarosław Sławek
prof. dr hab. n. med. Jarosław Sławek
Patient with dizziness in the course of PAF
Magdalena Witkowska, Karolina Porębska, Małgorzata Dec-Ćwiek
Case presentation: a 37-year-old woman with polyneuropathy and dyskinesias
Stanisław Szlufik, Barbara Pęczkowska, Dariusz Koziorowski
Two cases of myoclonus ataxia syndrome as a complication of SARS-CoV-2 infection
Filip Przytuła, Szymon Błądek, Jarosław Sławek
Generalised dystonia as another manifestation of familial neurodegenerative disease
Jarosław Dulski, Rafał Płoski
Reversible stuttering – case presentation
Justyna Kaczyńska, Piotr Janik
Breakthrough therapies in SMA - treatment outcomes for Spinraza and Evrysdi
Anna Łusakowska, Karolina Aragon-Gawińska, Anna Frączek, Anna Kostera-Pruszczyk
9:30 - 9:45
BREAK
9:45 - 11:15
NATIONAL CONSULTANT'S REVIEW SESSION
Chair:
Agnieszka Słowik
Agnieszka Słowik
The role of the Neurologist in innovation of novel neurotechnologies
Evolving therapy options for brain cancer and the role of a neurologist
Preventive strategies in epilepsy
Katarzyna Kotulska-Jóźwiak
Katarzyna Kotulska-Jóźwiak
11:15 - 11:30
BREAK
11:30 - 13:00
SESSION SPONSORED BY
Chair:
Monika Adamczyk-Sowa
Monika Adamczyk-Sowa
Mariusz Stasiołek
Mariusz Stasiołek
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
11:30 - 11:45
Rebif® in clinical practice – own experience from a center in Łódź
Mariusz Stasiołek
Mariusz Stasiołek
11:45 - 12:00
Rebif® – own experience from Poznań considering family planning
Karolina Piasecka-Stryczyńska
Karolina Piasecka-Stryczyńska
12:00 - 12:15
DISCUSSION
12:15 - 12:30
Long-term clinical efficacy and safety of MAVENCLAD®
Maciej Świat
12:30 - 12:50
Benefits of immune reconstitution therapy – MS follow-up also without active treatment
Monika Adamczyk-Sowa
Monika Adamczyk-Sowa
12:50 - 13:00
DISCUSSION
13:00 - 13:15
BREAK
8:00 - 9:30
NEW HORIZONS IN MULTIPLE SCLEROSIS
Chairs:
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
8:00 - 8:20
Big Data and artificial intelligence in MS
Marcin Mycko
Marcin Mycko
8:20 - 8:40
MRI still at the front line in MS
Frederik Barkhof
prof. dr hab. n. med. Frederik Barkhof
8:40 - 9:00
New horizons in MS treatment
9:00 - 9:20
European project on MS care unit
prof. Per Soerensen
9:20 - 9:30
DISCUSSION
9:30 - 9:45
BREAK
9:45 - 11:15
REVIEW SESSION OF THE SOCIETY OF PAEDIATRIC NEUROLOGY
Chairs:
Maria Mazurkiewicz-Bełdzińska
Maria Mazurkiewicz-Bełdzińska
Barbara Steinborn
Barbara Steinborn
9:45 - 10:05
Child with epileptic encephalopathy grown into adulthood
Maria Mazurkiewicz-Bełdzińska
Maria Mazurkiewicz-Bełdzińska
10:05 - 10:25
Child with cerebral palsy grown into adulthood
Barbara Steinborn
Barbara Steinborn
10:25 - 10:45
Child with myasthenia gravis grown into adulthood
10:45 - 11:05
Sense or nonsense – alternative therapies not only in paediatric neurology
Łukasz Przysło
Łukasz Przysło
11:05 - 11:15
DISCUSSION
11:15 - 11:30
BREAK
11:30 - 11:50
LECTURE SPONSORED BY
11:50 - 11:55
DISCUSSION
11:55 - 12:40
PRESENTATION SPONSORED BY
CURRENT LANDSCAPE OF POST -STROKE SPASTICITY MANAGEMENT - CAN WE DIAGNOSE AND TREAT IT?
Chair:
Jarosław Sławek
prof. dr hab. n. med. Jarosław Sławek
11:55 - 12:15
Current landscape of post-stroke spasticity - neurologist's and GP's perspective
Jarosław Sławek
prof. dr hab. n. med. Jarosław Sławek
12:15 - 12:35
Post-stroke spasticity and awareness of treatment options – perspective of patients and caregivers.
Iwona Sarzyńska-Długosz
Iwona Sarzyńska-Długosz
12:35 - 12:40
DISCUSSION
12:40 - 13:00
PRESENTATION SPONSORED BY Sandoz
Modern symptomatic treatment of patients with MS
Adam Stępień
Adam Stępień
13:00 - 13:15
BREAK
Hall A
13:15 - 15:15
PLENARY SESSION: INTERNATIONAL DANUBE SYMPOSIUM – PROGRESS IN NEUROLOGY
Konrad Rejdak
prof. dr hab. n. med. Konrad Rejdak
13:15 - 13:35
Update on dementia treatment
prof. Amos Korczyn
13:35 - 13:55
Recent progress in stroke management
Natan Bornstein
prof. dr hab. n. med. Natan Bornstein
13:55 - 14:15
Biomarkers for MS - recent developments
14:15 - 14:35
Recent progress in epilepsy management
Tim Von Oertzen
dr hab. n. med. Tim Von Oertzen
14:35 - 14:55
Dementia with lewy bodies and Parkinson's disease dementia- two independent disorders or one clinical entity within clinical spectrum of synucleinopathies
Ewa Papuć
Ewa Papuć
14:55 - 15:15
DISCUSSION
15:15 - 15:30
BREAK
15:30 - 16:30
SPONSORED SESSION BY
15:30 - 15:40
Opening address
Anna Członkowska
Anna Członkowska
15:40 - 16:00
Changes to ESO guidelines regarding therapy of acute ischemic strokes – selected topics
Bartosz Karaszewski
Bartosz Karaszewski
16:00 - 16:20
Qualifying patients to mechanical thrombectomy in a local stroke unit, rtPA administration and patient transportation
Adam Kobayashi
Adam Kobayashi
16:20 - 16:30
DISCUSSION
16:30 - 16:45
BREAK
15:30 - 16:30
SESSION SPONSORED BY
OZANIMOD IN THE EVALUATION OF MODERN ENDPOINTS FOR EFFICACY AND SAFETY IN RRMS MANAGEMENT – DO WE NEED NEW THERAPIES FOR MS?
Experts' discussion
Halina Bartosik-Psujek
Halina Bartosik-Psujek
Alina Kułakowska
prof. dr hab. n. med. Alina Kułakowska
16:30 - 16:45
BREAK
Hall A
16:45 - 18:15
PLENARY SESSION: IMAGING AND DISEASE MONITORING IN NEUROLOGICAL DISORDERS
Chairs:
Jerzy Walecki
Jerzy Walecki
Agata Majos
Agata Majos
16:45 - 17:00
White matter diseases - a challenge to a neuroradiologist
Monika Bekiesińska-Figatowska
Monika Bekiesińska-Figatowska
17:00 - 17:15
Neuroimaging in MS
Agata Majos
Agata Majos
17:15 - 17:30
A tumour or tumour-like lesion in the spinal cord?
Edyta Maj
17:30 - 17:45
Radiogenomics in malignant gliomas - new diagnostic approach.
Jerzy Walecki
Jerzy Walecki
17:45 - 18:00
Neuroimaging in ischaemic stroke – state of the art
Bartosz Mruk
18:15 - 18:30
BREAK
18:30 - 19:30
Announcement of venue for the next congress
19:30
CLOSING REMARKS